Javascript must be enabled to continue!
Hepatitis Management in Saudi Arabia: Trends, Prevention, and Key Interventions (2016–2025)
View through CrossRef
Background: Hepatitis presents a major health and economic challenge in Saudi Arabia, necessitating insight into its epidemiology, risk factors, and control measures. This review aims to synthesize current evidence on the epidemiology, risk factors, and prevention strategies for viral hepatitis in Saudi Arabia. It evaluates the effectiveness of existing interventions and proposes data-driven approaches to advance national hepatitis elimination goals. Methods: This study reviewed data from 2016 to 2024, sourced from PubMed, Google Scholar, ResearchGate, and ScienceDirect, focusing on hepatitis epidemiology and prevention in Saudi Arabia. Studies relevant to Saudi-specific trends and prevention strategies were included. Results: Saudi Arabia has achieved significant reductions in viral hepatitis prevalence, notably HBV (1.3%) due to universal infant vaccination (98% coverage), and HCV (0.124%) through the Saudi National Hepatitis Program (SNHP), which provides free DAAs (95% cure rate) and has screened 5 million people. However, challenges persist: HAV susceptibility is rising in adults (seroprevalence 33.1%), HDV affects 7.7% of HBV patients, and key risk factors include socioeconomic disparities (higher HAV/HEV in rural/low-income areas), intravenous drug use (30–50% of HCV cases), unsafe medical/cultural practices (e.g., Hijama), and limited healthcare access for migrants/rural populations. While interventions like water sanitation initiatives (58% HAV decline) and prenatal screening are effective, advancing elimination goals requires addressing gaps in HDV/HEV surveillance, outdated seroprevalence data, equitable treatment access (35% lower in rural areas), stigma reduction, and targeted strategies for high-risk groups to meet WHO 2030 targets. Conclusions: Saudi Arabia has made significant progress in hepatitis control through vaccination and public health efforts, but challenges persist. Strengthening healthcare systems, improving community engagement, and ensuring equitable access are key to sustaining elimination efforts.
Title: Hepatitis Management in Saudi Arabia: Trends, Prevention, and Key Interventions (2016–2025)
Description:
Background: Hepatitis presents a major health and economic challenge in Saudi Arabia, necessitating insight into its epidemiology, risk factors, and control measures.
This review aims to synthesize current evidence on the epidemiology, risk factors, and prevention strategies for viral hepatitis in Saudi Arabia.
It evaluates the effectiveness of existing interventions and proposes data-driven approaches to advance national hepatitis elimination goals.
Methods: This study reviewed data from 2016 to 2024, sourced from PubMed, Google Scholar, ResearchGate, and ScienceDirect, focusing on hepatitis epidemiology and prevention in Saudi Arabia.
Studies relevant to Saudi-specific trends and prevention strategies were included.
Results: Saudi Arabia has achieved significant reductions in viral hepatitis prevalence, notably HBV (1.
3%) due to universal infant vaccination (98% coverage), and HCV (0.
124%) through the Saudi National Hepatitis Program (SNHP), which provides free DAAs (95% cure rate) and has screened 5 million people.
However, challenges persist: HAV susceptibility is rising in adults (seroprevalence 33.
1%), HDV affects 7.
7% of HBV patients, and key risk factors include socioeconomic disparities (higher HAV/HEV in rural/low-income areas), intravenous drug use (30–50% of HCV cases), unsafe medical/cultural practices (e.
g.
, Hijama), and limited healthcare access for migrants/rural populations.
While interventions like water sanitation initiatives (58% HAV decline) and prenatal screening are effective, advancing elimination goals requires addressing gaps in HDV/HEV surveillance, outdated seroprevalence data, equitable treatment access (35% lower in rural areas), stigma reduction, and targeted strategies for high-risk groups to meet WHO 2030 targets.
Conclusions: Saudi Arabia has made significant progress in hepatitis control through vaccination and public health efforts, but challenges persist.
Strengthening healthcare systems, improving community engagement, and ensuring equitable access are key to sustaining elimination efforts.
Related Results
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
To assess possible role of testing for IgM-specific antibody in the diagnosis and monitoring of patients with hepatitis C, we tested sera from 14 patients with acute and 97 patient...
Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays
Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays
We longitudinally studied 51 patients from two hemodialysis centers to determine the prevalence of hepatitis C virus infection in hemodialysis patients. Serum samples were tested f...
Simon MABON, The Struggle for Supremacy in the Middle East: Saudi Arabia and Iran; Ibrahim FRAIHAT, Iran and Saudi Arabia: Taming a Chaotic Conflict; Talal MOHAMMAD, Iranian-Saudi Rivalry Since 1979: In the Words of Kings and Clerics
Simon MABON, The Struggle for Supremacy in the Middle East: Saudi Arabia and Iran; Ibrahim FRAIHAT, Iran and Saudi Arabia: Taming a Chaotic Conflict; Talal MOHAMMAD, Iranian-Saudi Rivalry Since 1979: In the Words of Kings and Clerics
This review endeavors to identify key themes and critical perspectives discernible in the scholarship of Simon Mabon’s The Struggle for Supremacy in the Middle East: Saudi Arabia a...
The Contextual Dynamism of Organizational Leadership in Saudi Arabia: What is Next After Change, Transition, and Transformation - Is it Transmogrification?
The Contextual Dynamism of Organizational Leadership in Saudi Arabia: What is Next After Change, Transition, and Transformation - Is it Transmogrification?
Saudi Arabia continues to undergo significant change and transformation as it shifts from an oil-dependent economy to diversification. Through the Vision 2030 framework, the leader...
Hepatitis C Viremia in Patients With Hepatitis C Virus Infection
Hepatitis C Viremia in Patients With Hepatitis C Virus Infection
Sera from 103 patients were tested for hepatitis C virus RNA by nested polymerase chain reaction assay. Using primers from the highly conserved 5′untranslated region, we detected h...
Trend analysis of hepatitis B and C among patients visiting health facility of Tigrai, Ethiopia, 2014–2019
Trend analysis of hepatitis B and C among patients visiting health facility of Tigrai, Ethiopia, 2014–2019
Abstract
Background
Hepatitis B and C viruses are the major public health concerns of the globe. The two hepatotropic viruses share common modes of ...
HLA antigens in patients with various courses after hepatitis B virus infection
HLA antigens in patients with various courses after hepatitis B virus infection
The course after hepatitis B virus infection seems to be determined by the host's immune response, which in turn may be regulated by the major histocompatibility complex. In order ...


